We aim to understand the morphogenesis, homeostasis and disease pathogenesis of lymphatic vessels and blood vessels and their microenvironments to provide new strategies for regenerative medicine and treatment of cancer, immune diseases, and edema. To this end, we are working to develop novel three-dimensional (3D) organ-on-chip systems, cellular and molecular tools, and in vivo models to better understand the mechanisms by which cells regulate and respond to biological and mechanical cues.
March 6, 2020:
Keng-Jung has been selected as one of the featured speakers at the Biomedical Engineering and Instrumentation Summit in Boston (BEIS-Boston). He will present his promising work on cancer-on-a-chip in July 2020. Congratulations! See the featured speakers.
January 29, 2020:
January 13, 2020:
Hyoann’s proposal entitled “Human small intestine on-a-chip” has been selected to receive a Spring 2020 research award from Cornell Engineering Learning Initiative (ELI). Congratulations, Hyoann!
December 5, 2019:
Dr. Lee gives an invited talk at the ASCB/EMBO 2019 meeting in Washington DC (Dec. 7-11, 2019).
September 5, 2019:
Dr. Lee has been appointed to the title of “Nancy and Peter Meinig Family Investigator in the Life Sciences” by the Office of the Provost at Cornell University. This title is an honor based on his achievements, promise and innovative future interdisciplinary research. – about the Meinig Family Investigator
August 28, 2019:
Our pancreatic cancer on-chip study has been published at Science Advances. Check out Harvard Wyss research highlight: “Exposing how pancreatic cancer does its dirty work”.
“To create and nurture a diverse community dedicated to discovery, scholarship, and leadership to improve human health and wellness by taking principles from engineering, biology, and medicine” – Lee lab mission.